Prebiotics are nondigestible food agents that stimulate the growth of bacteria in the gut, whereas probiotics are live microorganisms that replace or restore beneficial bacteria in the digestive tract. Both agents have been shown to have beneficial qualities within the microbiota-gut-brain axis, but the behavioural effects of prebiotics have been less studied than probiotics. Whereas several studies have shown that prebiotics reduce inflammation and modulate anxiety in animals that are injected with lipopolysacccharides or chronically stressed animals, respectively, it is not yet known how they affect a healthy organism. Here, we tested the behavioural effects of galacto-oligosaccharides and beta glucan as a commercially available prebiotic blend in healthy, naïve Sprague-Dawley rats. We used the open field test and elevated plus maze to assess anxiety-like behaviour in controls and in rats that ingested the prebiotic blend in their drinking water. We also used the Morris Water Maze to assess spatial memory performance in controls and prebiotic treated rats. Rats treated with prebiotics spent more time in the intermediate zone of the open field test and in the open arms of the elevated plus maze, and exhibited a shorter latency to enter each of these zones. No significant differences between groups were found in the Morris Water Maze. Our results suggest that whereas prebiotics significantly reduced anxiety-like behaviours, it had no effect on spatial memory performance. Altogether, our data indicate that commercially available prebiotic beta glucan blends have anxiolytic effects in healthy rats.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
Andersson, H., Asp, N.G., Bruce, Å., Roos, S., Wadström, T. and Wold, A.E., 2001. Health effects of probiotics and prebiotics: a literature review on human studies. Näringsforskning 45: 58-75. https://doi.org/10.3390/nu9091021
Bercik, P., Collins, S.M. and Verdu, E.F., 2012 Microbes and the gut-brain axis. Journal of Neurogastroenterology and Motility 24: 405-413. https://doi.org/10.1111/j.1365-2982.2012.01906.x
Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K.D., Verdu, E.F. and Verdu, E.F., 2011. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141: 599-609. https://doi.org/10.1053/j.gastro.2011.04.052
Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., Bienenstock, J. and Cryan, J.F., 2011. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences of the USA 108: 16050-16055. https://doi.org/10.1073/pnas.1102999108
Burokas, A., Arboleya, S., Moloney, R.D., Peterson, V.L., Murphy, K., Clarke, G., Stanton, C., Dinan, T.G. and Cryan, J.F., 2017. Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biological Psychiatry 82: 472-487. https://doi.org/10.1016/j.biopsych.2016.12.031
Campos, A.C., Fogaca, M.V., Aguiar, D.C. and Guimaraes, F.S., 2013. Animal models of anxiety disorders and stress. Brazilian Journal of Psychiatry 35: S101-S111. https://doi.org/10.1590/1516-4446-2013-1139
Carola, V., D’Olimpio, F., Brunamonti, E., Mangia, F. and Renzi, P., 2002. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behavioural Brain Research 134: 49-57. https://doi.org/10.1016/s0166-4328(01)00452-1
Chunchai, T., Thunapong, W., Yasom, S., Wanchai, K., Eaimworawuthikul, S., Metzler, G., Lungkaphin, A., Pongchaidecha, A., Sirilun, S., Chaiyasut, C. and Pratchayasakul, W., 2018. Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats. Journal of Neuroinflammation 15: 11. https://doi.org/10.1186/s12974-018-1055-2
Collins, S.M., Surette, M. and Bercik, P., 2012. The interplay between the intestinal microbiota and the brain. Nature Reviews Microbiology 10: 735-742. https://doi.org/10.1038/nrmicro2876
Cryan, J.F. and Dinan, T.G., 2012. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience 13: 701-712. https://doi.org/10.1038/nrn3346
Dinan, T.G. and Cryan, J.F., 2012. Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendrocrinology 37: 1369-1378. https://doi.org/10.1016/j.psyneuen.2012.03.007
Dinan, T.G. and Cryan, J.F., 2015. The impact of gut microbiota on brain and behaviour: implications for psychiatry. Current Opinions in Clinical Nutrition and Metabolic Care 18: 552-558. https://doi.org/10.1097/MCO.0000000000000221
Dinan, T.G., Stanton, C. and Cryan, J.F., 2013. Psychobiotics: a novel class of psychotropic. Biololgical Psychiatry 74: 720-726. https://doi.org/10.1016/j.biopsych.2013.05.001
Ferrarese, R., Ceresola, E.R., Preti, A. and Canducci, F., 2018. Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era. European Review for Medical and Pharmacological Sciences 22: 7588-7605. https://doi.org/10.26355/eurrev_201811_16301
File, S.E., 1992. Behavioural detection of anxiolytic action. In: Elliott, J.M., Heal, D.J., Marsden, C.A. (eds.) Experimental approaches to anxiety and depression. Wiley, New York, NY, USA, pp. 25-44.
'Behavioural detection of anxiolytic action ', () 25 -44.
Foster, J.A. and Neufeld, K.A.M., 2013. Gut-brain axis: how the microbiome influences anxiety and depression. Trends in Neuroscience 36: 305-312. https://doi.org/10.1016/j.tins.2013.01.005
Graham, B.M. and Daher, M., 2016. Estradiol and progesterone have opposing roles in the regulation of fear extinction in female rats. Neuropsychopharmacology 41: 774-780. https://doi.org/10.1038/npp.2015.202
Grimaldi, R., Gibson, G.R., Vulevic, J., Giallourou, N., Castro-Mejía, J.L., Hansen, L.H., Gibson, E.L., Nielsen, D.S. and Costabile, A., 2018. A prebiotic intervention study in children with autism spectrum disorders (ASDs). Microbiome 6: 133. https://doi.org/10.1186/s40168-018-0523-3
Gronier, B., Savignac, H.M., Di Miceli, M., Idriss, S.M., Tzortzis, G., Anthony, D. and Burnet, P.W.J., 2017. Increased cortical neuronal responses to NMDA and improved attentional set-shifting performance in rats following prebiotic (B-GOS) ingestion. European Neuropsychopharmacology 28: 211-224. https://doi.org/10.1016/j.euroneuro.2017.11.001
Hardy, H., Harris, J., Lyon, E., Beal, J. and Foey, A.D., 2013. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5: 1869-1912. https://doi.org/10.3390/nu5061869
Kao, A.C.C., Burnet, P.W.J. and Lennox, B.R., 2018. Can prebiotics assist in the management of cognition and weight gain in schizophrenia? Psychoneuroendocrinology 95: 179-185.
'Can prebiotics assist in the management of cognition and weight gain in schizophrenia? ' () 95 Psychoneuroendocrinology : 179 -185.
Kraeuter, A.K., Guest, P.C. and Sarnyai, Z., 2019. The open field test for measuring locomotor activity and anxiety-like behavior. In: Guest, O.C. (ed.) Pre-clinical models. Methods in molecular biology, vol. 1916. Springer, Heidelberg, Germany, pp. 99-103. https://doi.org/10.1007/978-1-4939-8994-2_9
Kumar, V., Bhat, Z.A. and Kumar, D., 2013. Animal models of anxiety: a comprehensive review. Journal of Pharmacological and Toxicological Methods. Journal of Pharmacological and Toxicological Methods 68: 175-183.
'Animal models of anxiety: a comprehensive review ' () 68 Journal of Pharmacological and Toxicological Methods : 175 -183.
Lach, G., Schellekens, H., Dinan, T.G. and Cryan, J.F., 2018. Anxiety, depression, and the microbiome: a role for gut peptides. Neurotherapeutics 15: 36-59. https://doi.org/10.1007/s13311-017-0585-0
Lister, R.G., 1987. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92: 180-185. https://doi.org/10.1007/BF00177912
Liu, S., Li, F. and Zhang, X., 2019. Structural modulation of gut microbiota reveals Coix seed contributes to weight loss in mice. Applied Microbiology and Biotechnology 103: 5311-5321. https://doi.org/10.1007/s00253-019-09786-z
National Research Council, 2011. Guide for the care and use of laboratory animals, 8th edition. The National Academies Press, Washington, DC, USA.
Neufeld, K.A.M., Kang, N., Bienenstock, J. and Foster, J.A., 2011. Effects of intestinal microbiota on anxiety-like behavior. Communicative and Integrative Biology 4: 492-494. https://doi.org/10.4161/cib.4.4.15702
Nunez, J., 2008. Morris water maze experiment. Journal of Visualized Experiments 19: 897. https://doi.org/10.3791/897
Pellow, S. and File, S.E., 1986. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacology Biochemistry and Behavior 24: 525-529. https://doi.org/10.1016/0091-3057(86)90552-6
Prut, L. and Belzung, C., 2003. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review. European Journal of Pharmacology 463: 3-33.
'The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review ' () 463 European Journal of Pharmacology : 3 -33.
Rao, A.V., Bested, A.C., Beaulne, T.M., Katzman, M.A., Iorio, C., Berardi, J.M. and Logan, A.C., 2009. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathogens 1: 6. https://doi.org/10.1186/1757-4749-1-6
Rodgers, R.J., Cole, J.C., Aboualfa, K. and Stephenson, L.H., 1995. Ethopharmacological analysis of the effects of putative ‘anxiogenic’ agents in the mouse elevated plus-maze. Pharmacology Biochemistry and Behavior 52: 805-813. https://doi.org/10.1016/0091-3057(95)00190-8
Rook, G.A., Raison, C.L. and Lowry, C.A., 2014. Microbiota, immunoregulatory old friends and psychiatric disorders. Advances in Experimental Medicine and Biology 17: 319-356. https://doi.org/10.1007/978-1-4939-0897-4_15
Savignac, H.M., Corona, G., Mills, H., Chen, L., Spencer, J.P., Tzortzis, G. and Burnet, P.W., 2013. Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine. Neurochemistry International 63: 756-764. https://doi.org/10.1016/j.neuint.2013.10.006
Savignac, H.M., Couch, Y., Stratford, M., Bannerman, D.M., Tzortzis, G., Anthony, D.C. and Burnet, P.W., 2016. Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice. Brain, Behavior, and Immunity 52: 120-131. https://doi.org/10.1016/j.bbi.2015.10.007
Savignac, H.M., Kiely, B., Dinan, T.G. and Cryan, J.F., 2014. Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Journal of Neurogastroenterology and Motility 26: 1615-1627. https://doi.org/10.1111/nmo.12427
Stuart, M.J., Singhal, G. and Baune, B.T., 2015. Systematic review of the neurobiological relevance of chemokines to psychiatric disorders. Frontiers in Cellular Neuroscience 9: 357. https://doi.org/10.3389/fncel.2015.00357
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., Kubo, C. and Koga, Y., 2004. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. Journal of Physiology 558: 263-275. https://doi.org/10.1113/jphysiol.2004.063388
Tarr, A.J., Galley, J.D., Fisher, S.E., Chichlowski, M., Berg, B.M. and Bailey, M.T., 2015. The prebiotics 3′ Sialyllactose and 6′ Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: evidence for effects on the gut-brain axis. Brain, Behavior, and Immunity 50: 166-177. https://doi.org/10.1016/j.bbi.2015.06.025
Vulevic, J., Juric, A., Tzortzis, G. and Gibson, G.R., 2013. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. The Journal of Nutrition 143: 324-331. https://doi.org/10.3945/jn.112.166132
Walf, A.A. and Frye, C.A., 2007. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nature Protocols 2: 322-328. https://doi.org/10.1038/nprot.2007.44
Waworuntu, R., Chichlowski, M., Cox, S. and Berg, B., 2014. Dietary prebiotics modulate fecal microbiota and impact cognitive functions in developing rodents. Federation of American Societies for Experimental Biology 28: LB376. https://doi.org/10.1096/fasebj.28.1_supplement.lb376
Wohleb, E.S., Fenn, A.M., Pacenta, A.M., Powell, N.D., Sheridan, J.F. and Godbout, J.P., 2012. Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice. Psychoneuroendocrinology 37: 1491-1505. https://doi.org/10.1016/j.psyneuen.2012.02.003
Xu, M., Mo, X., Huang, H., Chen, X., Liu, H., Peng, Z., Chen, L., Rong, S., Yang, W., Xu, S. and Liu, L., 2020. Yeast β-glucan alleviates cognitive deficit by regulating gut microbiota and metabolites in Aβ 1-42-induced AD-like mice. International Journal of Biological Macromolecules 161: 258-270. https://doi.org/10.1016/j.ijbiomac.2020.05.180
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 714 | 244 | 14 |
| Full Text Views | 15 | 5 | 0 |
| PDF Views & Downloads | 31 | 12 | 0 |
Prebiotics are nondigestible food agents that stimulate the growth of bacteria in the gut, whereas probiotics are live microorganisms that replace or restore beneficial bacteria in the digestive tract. Both agents have been shown to have beneficial qualities within the microbiota-gut-brain axis, but the behavioural effects of prebiotics have been less studied than probiotics. Whereas several studies have shown that prebiotics reduce inflammation and modulate anxiety in animals that are injected with lipopolysacccharides or chronically stressed animals, respectively, it is not yet known how they affect a healthy organism. Here, we tested the behavioural effects of galacto-oligosaccharides and beta glucan as a commercially available prebiotic blend in healthy, naïve Sprague-Dawley rats. We used the open field test and elevated plus maze to assess anxiety-like behaviour in controls and in rats that ingested the prebiotic blend in their drinking water. We also used the Morris Water Maze to assess spatial memory performance in controls and prebiotic treated rats. Rats treated with prebiotics spent more time in the intermediate zone of the open field test and in the open arms of the elevated plus maze, and exhibited a shorter latency to enter each of these zones. No significant differences between groups were found in the Morris Water Maze. Our results suggest that whereas prebiotics significantly reduced anxiety-like behaviours, it had no effect on spatial memory performance. Altogether, our data indicate that commercially available prebiotic beta glucan blends have anxiolytic effects in healthy rats.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 714 | 244 | 14 |
| Full Text Views | 15 | 5 | 0 |
| PDF Views & Downloads | 31 | 12 | 0 |